Biodyne Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Revenue	5,774	7,028	5,271
Other Revenue	-	-0	-
Revenue	5,774	7,028	5,271
Revenue Growth	-	33.32%	-
Cost of Revenue	2,253	2,560	2,834
Gross Profit	3,521	4,468	2,438
Selling, General & Admin	2,114	2,404	3,027
Research & Development	214.75	272.16	251.76
Amortization of Goodwill & Intangibles	834.34	851.78	473.19
Other Operating Expenses	15.67	22.38	23.41
Operating Expenses	3,444	3,816	4,168
Operating Income	77.13	652.26	-1,730
Interest Expense	-0.16	-0.16	-0.17
Interest & Investment Income	377.89	547.96	587.38
Currency Exchange Gain (Loss)	668.46	-459.92	705.35
Other Non Operating Income (Expenses)	131.83	-6.58	-19.12
EBT Excluding Unusual Items	1,255	733.56	-456.37
Gain (Loss) on Sale of Investments	226.96	354.05	259.52
Gain (Loss) on Sale of Assets	-4.61	20.8	55.75
Asset Writedown	-277	-277	-
Pretax Income	1,201	831.42	-141.1
Income Tax Expense	-22.28	-20.18	-151.87
Net Income	1,223	851.59	10.77
Net Income to Common	1,223	851.59	10.77
Net Income Growth	-	7806.89%	-
Shares Outstanding (Basic)	28	29	29
Shares Outstanding (Diluted)	28	29	29
Shares Change	-	-	-
EPS (Basic)	42.94	28.89	0.37
EPS (Diluted)	42.94	28.89	0.37
EPS Growth	-	7806.90%	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-2,869	-2,601	338.26
Free Cash Flow Per Share	-100.72	-88.24	11.48
Gross Margin	60.97%	63.57%	46.25%
Operating Margin	1.34%	9.28%	-32.81%
Profit Margin	21.18%	12.12%	0.20%
Free Cash Flow Margin	-49.68%	-37.01%	6.42%
EBITDA	1,349	1,980	-107.9
EBITDA Margin	23.37%	28.17%	-2.05%
D&A For EBITDA	1,272	1,328	1,622
EBIT	77.13	652.26	-1,730
EBIT Margin	1.34%	9.28%	-32.81%